Navigation Links
Stem cell microenvironment reverses malignant melanoma

Northwestern University researchers have demonstrated how the microenvironments of two human embryonic stem cell (hESC) lines (federally approved) induced metastatic melanoma cells to revert to a normal, skin cell-like type with the ability to form colonies similar to hESCs. The researchers also showed that these melanoma cells were less invasive following culture on the microenvironments of hESCs.

"Our observations highlight the potential utility of isolating the factors within the hESC microenvironment responsible for influencing tumor cell fate and reversing the cancerous properties of metastatic tumor cells, such as melanoma," said Mary J. C. Hendrix, in whose laboratories at Children's Memorial Research Center the experiments were conducted.

An article describing the findings by Hendrix and her laboratory group was published in the Nov. 17 online issue of the journal Stem Cells. Hendrix is president and scientific director of the Children's Memorial Research Center at Northwestern University Feinberg School of Medicine and a member of the executive committees of The Robert H. Lurie Comprehensive Cancer Center and the Center for Genetic Medicine at Northwestern University. The Northwestern researchers used a unique, three-dimensional model to test whether the microenvironment supporting human embryonic stem cells (hESCs) would influence the behavior of human metastatic melanoma cells ?since hESCs have the ability to develop into a variety of normal cell types ?to assume a more normal melanocyte-like cell, the skin cell type of origin for melanoma.

The model, which was developed in Hendrix's laboratories, consists of a three-dimensional collagen matrix preconditioned by hESCs, followed by their removal and subsequent application, or seeding, of metastatic melanoma cells onto the embryonic microenvironment, which was followed by molecular and functional analyses.

The team applied two different hESC lines, independently, onto three- dimensional collagen matrices and allowed the cells to form colonies and precondition their microenvironments for several days. The hESCs were removed and the matrix microenvironments were left intact. Then, human metastatic melanoma cells were seeded onto the hESC-preconditioned matrix microenvironment and were allowed to remain for several days. After this period, the metastatic melanoma cells exposed to the hECS microenvironment were reprogrammed to express a melanocyte-associated protein, called Melan-A, and form colonies similar to the hESC colonies. The melanoma cells reprogrammed by the hESC microenvironment were also less invasive than the tumor cells that had not been exposed to the embryonic matrices.

"These findings offer a new approach to investigating the possible effects of identifying the microenvironmental factors produced by hESCs on reversing the metastatic properties of tumor cells," Hendrix said.


'"/>

Source:Northwestern University


Related biology news :

1. Stem cell identity in culture may strongly depend on the cellular microenvironment
2. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
3. Genetic therapy reverses nervous system damage in animal model of inherited human disease
4. Gene therapy reverses genetic mutation responsible for heart failure in muscular dystrophy
5. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
6. Changing length of days reverses how estrogen affects aggressiveness in mice
7. Newfound roadblock to interferon effectiveness against malignant melanoma
8. Researchers discover why melanoma is so malignant
9. Possible birthplace of malignant brain tumors identified
10. Researchers test new therapy for advanced melanoma
11. Researchers use trickery to create immune response against melanoma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg ... Hereditary Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads ... eye drops in a group of 20 patients carrying 11778, 14484 and 3460 mutations ...
(Date:4/27/2017)... ... April 27, 2017 , ... During the course ... how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn the ... dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, will ...
(Date:4/27/2017)... USA (PRWEB) , ... April 27, 2017 , ... ... optics and photonics , joined other scientists, researchers, engineers, and industry professionals in ... to strengthen America's ability to compete in the world photonics industry. , This ...
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished ... products, today announces the appointment of Thomas C. ... Alexander ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive ... advisor to Kinexum clients. Thomas Seoh ... on the Kinexum mission and lead the firm,s remarkable ...
Breaking Biology Technology: